Navigation Links
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell

eriments showed gene activity was limited to pancreatic cancer cells and was minimal or absent from other cancers and three lines of normal pancreatic, lung and breast cells.

The next step was to load the vector with a weapon. The team packaged its mutant version of the Bik gene along with C-VISA in a liposome. For comparison, the liposomal gene also was attached to the CMV vector.

They tested both systems in the lab against all 13 available human cell lines of pancreatic cancer available worldwide. BikDD killed cells in all lines, with the VISA-delivered gene destroying more cells in all but one case. The C-VISA system spared healthy tissue while CMV-BikDD destroyed healthy cells. Subsequent tests compared the two methods in the mouse models.

Hung's team continues research on gene expression vehicle. "VISA is versatile enough that if you change the promoter, you could target other cancers or even other diseases," Hung says.

Research was funded by Abbruzzese's pancreatic cancer SPORE grant from the NCI, M. D. Anderson's NCI center support grant, a grant from the Topfer Research Funds, and an AstraZeneca Fellowship.

M. D. Anderson has filed for a patent on VISA-BikDD, which has been licensed to Alchemgen Therapeutics Inc. (ATI). ATI partially supports Hung's research. Hung and M. D. Anderson own stock in the company. These arrangements are managed by M. D. Anderson in accordance with its conflict of interest policies.

Co-authors of the Cancer Cell paper with Hung, Abbruzzese and Xie are: Weiya Xia, Hsu-Ping Kuo, Yuanfang Liu, Zheng Li, Qingqing Ding, Su Zhang, Bill Spohn, Yan Yang, Yongkun Wei, and Jing-Yu Lang, all of the Department of Molecular and Cellular Oncology; and Zhongkui Li, Douglas B. Evans, and Paul J. Chiao, all of the Department of Surgical Oncology. Kuo and Hung also are affiliated with the Graduate School of Biomedical Sciences, operated jointly by M. D. Anderson and The University of Texas Health Science Cen
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
5. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
6. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
7. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
8. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
Post Your Comments:
(Date:8/28/2015)... Massachusetts and LONDON , August ... approach seamlessly connects ... continuum improving outcomes and the ...  (NYSE: PHG AEX: PHIA) today announced its presence at  ... latest cardiology solutions, including Heart Model A.I. , EchoNavigator and ...
(Date:8/27/2015)... 2015  A recent study by Feucht et ... the Arthrosurface HemiCAP® Wave implant, which is based ... design implant for isolated patellofemoral disease. While both ... pain scores, none of the patients in the ... 53% of the patients in the "onlay" group, ...
(Date:8/27/2015)... RIVERSIDE, Calif. , Aug. 27, 2015 /PRNewswire/ ... important milestone in the commercial development of the ... . The Smart Oxygen device, being developed by ... adjusts to a patient,s changing demand for oxygen ... that the 510 (k) submission for the Smart ...
Breaking Medicine Technology:Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... 23, 2012 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... M.D., Ph.D. , Lexicon,s president and chief executive officer, will ... Tuesday, February 28, 2012, at 10:30 a.m. Eastern Time.  Dr. ... and milestones. A live webcast of the ...
... 23, 2012 Millennium Laboratories announced today new ... prescribing practices that lead to better patient outcomes. ... (AAPM) Annual Meeting, Millennium is sponsoring two educational ... practices; and a symposium to address medication-taking behaviors ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference 2Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting 2Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting 3
(Date:8/28/2015)... ... 2015 , ... With the goal of furthering music education programs in schools, ... Adams County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by ... in the underfunded school districts of Mendon and its neighboring town of Quincy, IL. ...
(Date:8/28/2015)... ... 28, 2015 , ... The 6th Annual Survivor in the City, Chicago ... yet another accolade to its cadre of widespread support—an official letter of support and ... of the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, ...
(Date:8/28/2015)... , ... August 28, 2015 , ... “ Frequentz ” ... at the latest and coolest applications on the market for iOS, Android, and Windows. ... shared with viewers how this software allows businesses to track product movement from beginning ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... of the Veterans Award, honoring military veterans leading in business. Mr. Troy ... , The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize ...
(Date:8/28/2015)... ... , ... The Quatela Center for Plastic Surgery is excited to bring patients ... approved by the Food and Drug Administration to eliminate submental fat, also known as ... are among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... Calif., March 20 IPC The,Hospitalist Company, Inc. ... hospitalist,services, announced today the election of Woodrin Grossman ... on the audit and nominating and,governance committees., ... and healthcare practice,leader of PricewaterhouseCoopers after 37 years ...
... Affiliated Computer,Services, Inc. (NYSE: ACS ) announced ... provide business process outsourcing (BPO), information,technology outsourcing (ITO), ... Affordable Quality Healthcare. The multi-million dollar deal,has a ... options, including a,six-month implementation period., CAQH is ...
... G. Ryan, founder,and executive chairman of Aon Corporation, today ... 2008. Aon is the world,s largest,insurance and reinsurance intermediary, ... commented, "The transition to a new management team under ... extremely well-positioned,for continued growth and success. After 41 years ...
... yourself!" , Most of us haven,t heard that admonition ... often tell ourselves, consciously or not, as we deal ... regulate one,s emotions is critical to successfully interacting with ... an equally important effect on our own well-being. , ...
... Hughes Lists 2007 Accomplishments and Reiterates Plans for Growth, ... SMBL ) announced today that members of its ... Las Vegas, NV, at 12:25 p.m.,EDT on Wednesday, March ... present at the conference, Smart,Balance Chairman and CEO Stephen ...
... Osteoporosis drug also linked to bone pain and irregular heartbeats ... In the latest research to cast a shadow on ... long-term use of Fosamax is associated with unusual fractures of ... meaning that they all occurred from a fall from standing ...
Cached Medicine News:Health News:IPC The Hospitalist Company Announces Board of Director Member Changes 2Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 2Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 3Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 4Health News:Patrick G. Ryan Announces Intention to Retire from Aon 2Health News:Patrick G. Ryan Announces Intention to Retire from Aon 3Health News:Disgusting videos used to study coping methods 2Health News:Disgusting videos used to study coping methods 3Health News:Disgusting videos used to study coping methods 4Health News:Smart Balance Presented at Citi Small/Midcap Conference 2Health News:Fosamax Linked to Unusual Femur Fractures 2Health News:Fosamax Linked to Unusual Femur Fractures 3
... DxSelect is intended for qualitatively detecting antibodies ... serum. The test is indicated for testing ... an aid in the presumptive laboratory diagnosis ... intended for self-testing, and this test is ...
... immunofluorescent antibody (IFA) test ... semi-quantitation of human serum ... viral capsid antigen (VCA). ... 12-well slides, FITC IgG ...
... portable, battery-powered, micro-controlled, noninvasive bone growth stimulator ... primary lumbar spinal fusion surgery for one ... been shown in pre-clinical studies to help ... Clinical studies have also shown that individuals ...
... Siemens Medical Solutions introduces its new ... system with intuitive patient data management ... lithotripter and urological table. Lithoskop is ... urodiagnostics that covers all applications like ...
Medicine Products: